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Objective: We have found laparoscopic surgery to be both feasible and safe for large ovarian tumors,
which at one time would have been managed strictly by conventional laparotomy. The aim of this study
was to evaluate the potential risks and the outcomes of laparoscopic surgery for ovarian tumors on the
basis of tumor size.
Materials and methods: From among 1248 cases of adnexal tumor treated at our institution between June
2005 and June 2014, we identiﬁed 1196 cases of preoperatively diagnosed benign ovarian tumor treated
by laparoscopic surgery. We divided the cases into three groups according to the diameter of the tumor:
 5cm (Group A, n ¼ 355), 6e9 cm (Group B, n ¼ 688), and 10 cm (Group C, n ¼ 153) and investigated
the incidences of perioperative complications and the rates at which laparotomy was converted to open
surgery.
Results: Median operation time was 59 minutes, 7 minutes, and 73 minutes (p < 0.001) for Group A,
Group B, and Group C, respectively. Median estimated blood loss was 7 mL, 16 mL, and 32 mL (p < 0.001),
respectively. The perioperative complication rate (n ¼ 4, n ¼ 7, and n ¼ 4, respectively), did not differ
signiﬁcantly between groups nor did the rate of conversion to laparotomy (n ¼ 1, n ¼ 2, and n ¼ 2,
respectively). Tumor size was not a prognostic indicator of perioperative complications (Hazard Ratio
(HR), 0.96; 95% conﬁdence interval, 0.79e1.16; p ¼ 0.652).
Conclusion: Operation time and estimated blood loss were shown to increase with the size of an ovarian
tumor. However, we found no relation between tumor size and the perioperative complication rate or the
rate of conversion to open surgery. Thus, we conclude that tumor size is not a factor limiting application
of laparoscopic surgery to ovarian tumors.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Laparoscopic surgery is the gold standard for surgical treatment
of benign ovarian tumors.1 However, large ovarian tumors are
generally managed by conventional laparotomy.2 This is because
the narrow ﬁeld of view and the small operating space posed by
laparoscopic surgery makes the approach to large ovarian tumors
difﬁcult. The difﬁculties are multiplied in petite women, even forinterest to declare.
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nc-nd/4.0/).such procedures as trocar insertion. In addition, there is the
perceived higher malignant potential of large ovarian masses.3
Panici4 et al reported the feasibility and safety of laparoscopy-
assisted surgery for large ovarian tumors. Does size of the ovarian
tumor affect the outcome of laparoscopic surgery? No matter how
large the tumor, it may be possible to preserve ovarian function in
premenopausal women. The factors that limit a laparoscopic
approach to ovarian tumor are not well deﬁned.
Purpose/aims
We undertook a retrospective, comparative study of outcomes
in cases of presumed benign ovarian tumor treated by laparoscopic
surgery at our institution to determine the factors that limit
application of such surgery to ovarian tumors. Factors were
compared on the basis of tumor size.ly InvasiveTherapy. PublishedbyElsevier TaiwanLLC. This is anopenaccessarticleunder theCC
Table 1
Patient characteristics and type of surgery.
Variable n ¼ 1196
Age (y) 34.0 (29.0e40.1)
Body mass index (kg/m2) 20.2 (18.7e21.9)
Tumor diameter (cm) 6.0 (5.0e8.0)
Bilateral tumor (%) 352 (30.1)
Operation time (minutes) 66.0 (48.0e97.0)
Estimated blood loss (mL) 16.0 (1e67)
Hospital stay (d) 4.0 (3.0e5.0)
Operative procedure (n)
Ovarian conservation 1056
Salpingo-oophorectomy 140
Conversion to laparotomy (n) 4
Median (25the75th percentile) values are shown unless otherwise indicated.
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Case selection
From among 1248 cases of adnexal tumor treated at our insti-
tution between June 2005 and June 2014, we identiﬁed 1196 cases
of supposed benign ovarian tumor treated by laparoscopic surgery.
We had been given permission by the patients to use their records
(pictures during surgery, etc.) for the purpose of our study. We
restricted our selection of cases to those for which preoperative
imaging study for a measureable lesion had been performed and no
concomitant surgery, such as hysterectomy, transcervical resection,
urological surgery, or cholecystectomy had been performed. Also
excluded were cases of ovarian tumor accompanied by ascites or
swollen lymph nodes, those with irregular septum structures, and
those accompanied by gross metastatic disease.5 All patients had
provided general informed consent for their perioperative data to
be used for medical research.
We stratiﬁed the cases according to tumor size and investigated
the incidences of perioperative complications and the rates at
which laparotomy was converted to open surgery. All data were
extracted from patients' online records, i.e., the perioperative video
recording, operative report, and pathology report, and the periop-
erative period, as deﬁned, extended to 1 month after surgery. The
preoperative diagnoses were made by gynecologists and based on
pelvic examination, transvaginal ultrasound, pelvic magnetic
resonance imaging (MRI), and serum tumor maker (CA125)
assessment. An ovarian tumor was judged to be benign on the basis
of the following preoperative MRI and ultrasound features: pres-
ence of a single cystic tumor, absence of septae, absence of wall
thickening, and absence of a solid component.6 Absence of a solid
component was not taken in the strictest sense. If such a compo-
nent was present, absence of blood ﬂow was taken to indicate a
benign tumor. The required serum CA125 level was below or within
normal range. Laparoscopic surgery was performed for an ovarian
tumor diagnosed preoperatively as a benign tumor. The ﬁnal
diagnosis was determined by one of two pathologists.
Surgical method
The standard laparoscopic surgery method for ovarian tumor
requires insertion of three trocars. We inserted the ﬁrst trocar
above the patient's navel or at the navel by the direct method, and
we positioned the two other trocars according to the volume of the
ovarian tumor. In cases of extensive adhesion and tumor measuring
10 cm in diameter and thus occupying the pelvis, we added a
double balloon trocar at the suprapubic area. To reduce the risk of
intraperitoneal spillage, we used a SAND double-balloon catheter
(Hakko Medical, Tokyo, Japan), which sandwiches the entire tumor
between the two balloons. The catheter tip was used to aspirate the
tumor contents and thereby decrease the tumor volume, and the
tumor wall was freed from adhesion and removed from normal
ovarian tissue under laparoscopic assistance.7 The pneumo-
peritoneum pressure was maintained at 10 mmHg.
Comparative study
We divided patients into three groups according to the diameter
of the ovarian tumor:  5 cm (Group A), 6e9 cm (Group B), and
10 cm (Group C). Patient age, patient body mass index (BMI),
median tumor diameter, operation time, estimated blood loss,
hospitalization time (number of days), perioperative complication
rate, number of conversions to open surgery, and number of
pathologically identiﬁed borderline or malignant tumors were
compared between groups. Perioperative complicationwas deﬁnedas an intraoperative or postoperative complication occurring be-
tween the time of surgery and 4 weeks after surgery or hospital
discharge.8 Examples include injury to another organs during sur-
gery, trocar injury requiring treatment, bleeding requiring blood
transfusion, and readmissionwithin 1 month after surgery because
of postoperative ileus, infection, or wound dehiscence.
Statistical analysis
Results are shown as median values or percentages of patients.
Between-group differences were analyzed by KruskaleWallis test,
and between group differences were analyzed using the Man-
neWhitney U test. Factors that were shown by univariate analysis
to be potential risk factors perioperative complicationwere entered
into multivariate analysis. Odds ratios for perioperative complica-
tions and conversion to laparotomy were calculated with 95%
conﬁdence intervals. Statistical signiﬁcance was set at a p < 0.05.
SPSS II version 12.0 (SPSS Inc., Chicago, IL, USA) was used for all
statistical analyses.
Results
Patients were grouped according to tumor size as follows:
Group A (5 cm), 355 patients; Group B (6e8 cm), 688 patients;
Group C (10 cm), 153 patients. Patient characteristics and surgical
details are shown in Table 1. A total of 1056 (88%) patients under-
went laparoscopic ovarian functional preservation surgery. Only
four patients (0.33%) required conversion to laparotomy for which a
Pfannenstiel incision or low vertical incision was made. Two of the
conversions were necessitated by perioperative organ injury, one
was necessitated by severe adhesion, and one by a large calciﬁca-
tion within the tumor.
Surgical pathology results are given in Table 2. All but 14 tumors,
i.e., 98.8% of the tumors, proved to be benign. Of the 14 tumors that
proved to be malignant, one was considered a metastasis from
breast cancer. Eleven of the tumors were borderline malignancies,
with eight of these being mucinous tumors, two being stromal
carcinoid tumors, and one being a serous tumor.
Clinical and surgical details are shown per group in Table 3.
Median operation time was 59 minutes, 7 minutes, and 73 minutes
(p < 0.001) for Group A, Group B, and Group C, respectively. Median
estimated blood loss was 7 mL, 16 mL, and 32 mL (p < 0.001) for
Group A, Group B, and Group C, respectively. Hospital stay did not
differ signiﬁcantly between groups, nor did perioperative compli-
cation rates. No perioperative deaths occurred in this patient series.
Two patients experienced severe intraoperative complica-
tionsdorgan injury in both cases. One of the injuries required
temporary ileostomy, and the other required laparotomy for
bladder repair. Three patients were readmitted for postoperative
Table 2
Pathologic ﬁndings.
Histopathologic diagnosis No. of patients
Dermoid cyst 556
Endometrioid cyst 454
Serous cystadenoma 68
Mucinous cystadenoma 66
Tubal cyst (paraovarian cyst/hydrosalpinx) 18
Adenoﬁbroma/ﬁbroma 8
Struma ovarii 5
Mesothelial cyst 2
Thecoma 2
Puseudocyst 2
Benign Brenner tumor 1
LMP tumor 10
Malignant tumor 3
Metastatic tumor 1
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between groups. However, postoperative pathologic diagnoses did
differ signiﬁcantly between groups (n ¼ 3, n ¼ 4, and n ¼ 7
borderline or malignant tumors; p < 0.001) for Group A, Group B,
and Group C, respectively. Malignancy was signiﬁcantly more
prevalent in Group C than in the other two groups (p < 0.001). All
seven malignancies in Group C were borderline malignancies. Re-
sults of multivariate analysis are shown in Table 4. Tumor size didTable 3
Patient characteristics per study group.
Variable Group
A: 5 cm (n ¼ 355)
Tumor diameter (cm) 5.0
Age (years) 34.1
Body mass index (kg/m2) 20.1
Operation time (minutes) 59.0
Estimated blood loss (mL) 7.0
Hospital stay (days) 4.5
Perioperative complications (n) 4
Conversion to laparotomy (n) 1
Borderline or malignant tumor (n) 2
Groups are based on tumor size (diameter). Median values are shown unless otherwise
Table 4
Risk factors for perioperative complications.
Variable Complications (n) n Univariate
Hazard ratio
Tumor diameter
 10 cm 4 153 2.52 (0.79e8
>10 cm 11 1043 Reference
Age
 34 y 9 613 1.43 (0.51e4
>34 y 6 583 Reference
Obesity
Yes 0 30 0.01 (0.01e2
No 15 1151
Bilateral tumor
Yes 5 352 1.02（0.41-3
No 10 844
Operation time
 62 min 12 649 3.42 (0.95e1
>62 min 3 547 Reference
Estimated blood loss
 16 mL 12 600 4.03 (1.13e1
>16 mL 3 596 Reference
Hospitalization
 4 d 8 540 1.84 (0.65e5
>4 d 7 656 Reference
n, number of patients.
Obesity, body mass index S30 kg/m2.not remain a prognostic indicator of perioperative complications
(HR 0.96, 95% conﬁdence interval 0.79e1.16, p ¼ 0.652).Discussion
Laparoscopic surgery for large ovarian tumors is very difﬁcult
because the pelvic operating space is quite restrictive. Thus, oper-
ation time and estimated blood loss during surgery for a large
ovarian tumor were signiﬁcantly increased in our patient series.
However, neither the need for conversion to laparotomy nor the
number of complications arising during the perioperative period
were signiﬁcantly increased. Despite the poor intraabdominal
conditions, laparoscopic surgery for treatment of a large ovarian
tumor was shown to be technically feasible and safe if performed
properly.
In 2011, the Japan Society for Endoscope Surgery reported a
0.45% rate of conversion to laparotomy from laparoscopic surgery
for ovarian tumor and a perioperative complication rate of 1.3%9.
Chezzi et al10 reported attempted laparoscopic surgery in 186 pa-
tients with a large ovarian tumor 10 cm. Five (2.6%) of these pa-
tients required conversion to laparotomy, and three (1.6%) suffered
perioperative complications.10 In our patient series, the conversion
rate was 0.33%, and the complication rate was 1.25%, consistent
with reported rates.B:6e9 cm (n ¼ 688) C:  10 cm (n ¼ 153) P value
7.0 10.0 <0.001
34.0 34.5 0.836
20.3 20.3 0.134
67.0 73.0 <0.001
16.0 32.0 <0.001
4.5 4.7 0.140
7 4 0.256
1 2 0.078
4 7 <0.001
indicated.
(95%CI)
p value Multivariate
Hazard ratio (95%CI)
p value
.01) 0.118 0.96 (0.79e1.16) 0.652
Reference
.08) 0.498
.35) 0.789
.54) 0.739
2.1) 0.058 2.31 (0.62e13.7) 0.211
Reference
4.3) 3.53 (0.91e13.7)
0.031 Reference 0.068
.19) 0.252
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laparoscopic surgery for a large ovarian tumor, i.e., 10 cm, is
feasible and safe.11 Previously reported studies included only
pathologically similar tumors, and most of the laparoscopic sur-
geries reported were salpingo-oophorectomies,12 and the patient's
ovary could not be conserved.7,11,13 We conducted a comparative
study in which cases were categorized according to the tumor
diameter, as measured on preoperative images, and we assessed
the feasibility and safety of laparoscopic surgery in each size cate-
gory. By including tumors of various sizes and pathologic types that
had all been judged to be benign preoperatively, we explored fac-
tors that could possibly limit laparoscopic surgery for this clinical
entity. We found no signiﬁcant difference in the perioperative
complication rate or the risk of conversion to open surgery based
on size of the ovarian tumor.
We investigated factors related to complications that occurred
in the perioperative period. Operation time, estimated blood loss,
and tumor diameter were shown by univariate analysis to be po-
tential predictive factors for perioperative complications. However,
tumor diameter did not hold up under multivariate analysis as a
risk factor for perioperative complications. We also examined fac-
tors potentially predictive of conversion to laparotomy, but no
factors we examined were shown to be statistically signiﬁcant. This
could be because the number of events was too small for uncov-
ering predictive factors. Nevertheless, transition to laparotomy was
not associated with tumor size.
Large ovarian tumor remains a treatment dilemma for gyne-
cologists. A large ovarian tumor that is diagnosed as benign by
preoperative examination can prove to be malignant upon post-
operative pathology examination.4 In a survey conducted by the
American Association of Gynecologic Laparoscopists, unsuspected
ovarian cancer was found in only 0.04% of 13,739 cases of ovarian
cyst treated by laparoscopic surgery.14 Another group estimated the
risk to be between 0.9% and 13%.15 In cases of unexpected malig-
nancy, there is a risk of tumor rupture and spillage during laparo-
scopic surgery, and this of course could advance the tumor stage. It
remains uncertain whether intraoperative rupture affects prog-
nosis.16 Matsushita et al17 reported discovery of unexpected ovarian
malignancy in 1.5% of patients treated laparoscopically and that the
presence of an early-stage unexpected ovarian malignancy did not
alter prognosis. These data remind us that surgeons must use good
judgment and be selective when choosing cases for laparoscopic
management.
As diagnostic MRI and ultrasonography continue to develop and
accuracy continues to improve, few cases of malignancy are diag-
nosed postoperatively.17,18 We always perform MRI and a tumor
marker test preoperatively, but the possibility of malignancy is
never fully resolved before surgery. A ﬁnal postoperative pathologic
diagnosis is always provided.
Despite our preoperative tests, we had 10 cases of borderline
ovarian tumor, three cases of carcinoma, and one metastasis from
breast cancer. Radical surgery was eventually performed for our
fourmalignancies. Laparoscopic adnexectomy and a detailed search
of the peritoneal cavity were performed for the 10 borderline tu-
mors. We removed these tumors in retrieval bags to prevent
spillage and port-site metastasis. No recurrence or death from the
disease has occurred during the median follow-up of 914 days
(interquartile range: 171e2159 days).
Timmermann et al19 reported the size of an adnexal mass to be
an independent predictor of malignancy. According to our study,
the malignancy rate was signiﬁcantly increased among tumors
10 cm in diameter. Therefore, the potential risk of malignancy
rather than the tumor size itself should be considered a factor
limiting laparoscopic surgery.Tumor size did not appear to be related to the risk of compli-
cations or the need for conversion to laparotomy in our series. If
diagnosis by laparoscopic surgery is possible, unnecessary lapa-
rotomy is avoidable. Even if the surgical specimen is found to be
malignant, additional treatment can be provided in the early
postoperative period because laparoscopic surgery is minimally
invasive and leads to early recovery. Even when precautionary
laparoscopic adnexectomy is performed for a large ovarian tumor,
fertility can be preserved.
As this study was retrospective, the possibility of selection bias
must be taken into account. However, our institution specializes in
laparoscopic surgery, and >2000 laparoscopic procedures are per-
formed every year. In addition, all patients we treat are referred to
us by other hospitals. If, through preoperative study, we suspect a
malignant ovarian tumor, we refer the patient to an institution that
treats malignancies.
Operation time and estimated blood loss increase with the size
of the ovarian tumor. However, we found no relation between the
perioperative complication rate or rate of conversion to laparotomy
and tumor size in our patient series. The only difference was in the
prevalence of unexpected malignancies, which was greater among
patients with a large ovarian tumor. The aim of this study was to
evaluate the potential risks and the outcomes of laparoscopic sur-
gery for ovarian tumors on the basis of tumor size. We observed
that laparoscopic surgery was both feasible and safe for large
ovarian tumors, which at one time would have been managed
strictly by conventional laparotomy. Tumor size was not identiﬁed
as a factor limiting application of laparoscopic surgery. Our ﬁndings
may contribute to the expansion of indications for laparoscopic
surgery to include large ovarian tumors.References
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